
bioMérieux Investor Relations Material
Latest events

Q2 2025
bioMérieux
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from bioMérieux S.A
Access all reports
bioMérieux S.A. is a global biotechnology company that specializes in the development, manufacturing, and marketing of in vitro diagnostic solutions for medical and industrial applications. The company’s products include diagnostic tools for infectious diseases, oncology, cardiovascular diseases, and food safety testing. bioMérieux offers a range of systems, reagents, and software designed for microbiology, immunoassays, and molecular biology, helping healthcare providers and laboratories detect pathogens and analyze biological samples. The company also serves industrial markets, providing solutions for food safety, pharmaceutical quality control, and environmental monitoring. The company is headquartered in Marcy-l'Étoile, France, and its shares are listed on Euronext Paris.
Key slides for bioMérieux S.A


Q2 2025
bioMérieux S.A


Q2 2025
bioMérieux S.A
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
BIM
Country
🇫🇷 France